Abstract B234: LY2835219, a potent oral inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6) that crosses the blood-brain barrier and demonstrates in vivo activity against intracranial human brain tumor xenografts.
暂无分享,去创建一个
Thomas J. Raub | L. Gelbert | Concha Sánchez-Martínez | H. Shannon | G. Sawada | B. Staton | A. D. Dios | G. Wishart | R. Ajamie